OPKO Health (OPK) Tops Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Cantor Fitzgerald Maintains Bullish View on Opko Health (OPK) Following Beat
August 8, 2018 6:45 AM EDTCantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $20 price target on Opko Health (NASDAQ: OPK) following its Q2 EPS beat.
Chen commented, "We continue to think that the long-term sales and earnings potential of OPK's business is underappreciated and that upward... More



